Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
about
Association of Suicidality and Depression With 5α-Reductase Inhibitors.Germline BRCA mutation in male carriers-ripe for precision oncology?Pre-radiotherapy PSA progression is a negative prognostic factor in prostate cancer patients using 5‑alpha-reductase inhibitors.Redox Paradox: A novel approach to therapeutics-resistant cancer.
P2860
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@en
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@nl
type
label
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@en
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@nl
prefLabel
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@en
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@nl
P2093
P2860
P356
P1476
Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.
@en
P2093
Cathee Till
Catherine M Tangen
Ian M Thompson
Jason D Wright
Joseph M Unger
Lori M Minasian
Phyllis J Goodman
Scott D Ramsey
William E Barlow
P2860
P356
10.1093/JNCI/DJW168
P407
P577
2016-08-26T00:00:00Z